Institution
Andreas Sygros Hospital
Recent research
- Health & Medicine
Upcoming novel treatments for hidradenitis suppurativa: An overview of the pipeline
Abstract Recent developments in hidradenitis suppurativa (HS) have focused on targeting key inflammatory pathways implicated in the pathogenesis of the disease, including interleukin (IL)‐17, IL‐1, tumour necrosis factor (TNF), Janus kinase (JAK) and tyrosine kinase 2 (TYK2) sign...
- Health & Medicine
Background: Cutaneous adverse drug reactions (CADRs) occur in 2–5% of inpatients, primarily due to delayed (T-cell-mediated) reactions, such as maculopapular exanthemas (MPEs). The lymphocyte transformation test (LTT) detects drug-specific T-cell responses with varied sensitivity...
- Health & MedicineOpen access
Tebentafusp is a first-in-class bispecific fusion protein that redirects T cells toward gp100-expressing cells and represents the first systemic treatment shown to improve overall survival in patients with HLA-A*02:01-positive metastatic uveal melanoma. As gp100 is also expressed...
- Health & MedicineOpen access
Abstract Purpose Glucocorticoids (GCs) are steroid hormones produced by the adrenal cortex with anti-inflammatory and immunoregulating effects, thus essential for the management of numerous inflammatory and autoimmune disorders, including a wide range of dermatological conditions...
- Climate & EnvironmentOpen access
Carboxyl-modified polystyrene microplastics (cPS-MPs) may accumulate in the liver and interfere with cellular metabolism; however, their effects may differ substantially between cancerous and non-cancerous hepatocytes. In this study, we compared the responses of HUH-7 hepatocellu...
- Health & MedicineOpen access
BACKGROUND: This first part of the S2k guidelines is an update of the 2015 S1 European guidelines based on the structured assessment of clinically relevant topics by the panel of experts. It is complemented by Part 2, which deals with treatments. OBJECTIVES: These guidelines aim...